ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE) Stock Price, Fundamentals, Valuation & Analysis

🧬 TickerPulse Stock DNA

8-pillar deterministic fundamental framework with transparent methodology

Composite: Not available

⚡ What Changed? (Recent Signal Radar)

Real-time delta analysis across price discovery, institutional flows, and disclosures

Evidence-Backed Signals • Q3 FY25

Price Move ↓

-1.35%

Intraday consolidation aligning with broader sectoral price discovery.

Inspect Evidence →

Institutional Flow (FII/DII) 🏛️

Holding at 6.9%

Foreign & domestic institutions retain solid allocation across top-tier funds.

Inspect Evidence →

Capital Productivity ⚙️

ROE: 21.2%

Double-digit return on equity ensures sustainable organic balance sheet expansion.

Inspect Evidence →

Exchange Filings & Disclosures 📑

3 Verified Filings

Audited annual reports and earnings presentations submitted to BSE & NSE on schedule.

Inspect Evidence →

Forensic Solvency Radar 🛡️

0 Red Flags Detected

Piotroski health score and debt service coverage pass all standard regulatory thresholds.

Inspect Evidence →

📈 Price & Technical Intelligence

Interactive price action with toggleable 50/200 DMA, VWAP, Bollinger Bands, Volume, and RSI overlays

Overlays: 50 DMA 200 DMA Volume VWAP Bollinger (20,2) RSI (14)

Daily OHLC history · Upstox · Latest session: 09 Nov 2026

50-Day DMA ● Overlay

₹1,157.52

200-Day DMA ● Overlay

₹1,073.55

14-Day RSI ● Overlay

47.3 (Neutral)

Trend Signal

Strong Bullish

📐 Key Fundamentals & Valuation Multiples

Core financial metrics computed from live market prices and audited regulatory filings

Source: Exchange Disclosures • Q3 FY25

Market Cap Live Size

₹1.14 Lakh Cr

Large cap

Stock P/E (TTM) Valuation

23.5x

Price / EPS

Book Value (₹) Assets

₹269.0

P/B: 4.3x

ROE (%) Quality

21.2%

Net Profit / Equity

ROCE (%) Efficiency

21.1%

EBIT / Capital

Dividend Yield Yield

0.09%

Face Value: ₹10

Debt / Equity Solvency

0.46x

Manageable

EPS (TTM) Per Share

₹48.75

Trailing 12M

OPM (%) Spread

29.0%

EBITDA Margin

Free Cash Flow Cash

-₹530.00 Cr

CFO - Capex

About ZYDUS LIFESCIENCES Ltd

ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE) is an Indian publicly traded enterprise listed on the National Stock Exchange (NSE).

🧬 DuPont 3-Stage ROE Decomposition:

Margin: 20.9% × Turnover: 0.85x × Leverage: 1.46x = ROE: 21.2%

✓ Company Strengths (Pros)

• Company has a stellar track record of return on equity (ROE of 21.2%).
• Maintains healthy operating profit margins of ~29.0%.

⚠ Key Considerations & Risks (Cons)

• Valuation is sensitive to broader macroeconomic and sectoral interest rate cycles.

📑 10-Year Comprehensive Financial Statements

✓ 100% Coverage (15/15 Metrics)

Audited financial statements • Latest: Q3 FY25 (Dec 2024) / Audited FY24 • Source: Company Disclosures & BSE

Latest Sales

₹28,592 Cr

Latest PAT

₹4,593 Cr

EPS (TTM)

₹48.75

OPM %

29.0%

5Y Sales CAGR

14%

5Y Profit CAGR

18%

Swipe → to view historical periods

Quarter (₹ Cr)	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales / Revenue	₹5,140 Cr	₹4,369 Cr	₹4,505 Cr	₹5,534 Cr	₹6,208 Cr	₹5,237 Cr	₹5,269 Cr	₹6,528 Cr	₹6,574 Cr	₹6,123 Cr	₹6,864 Cr	₹7,587 Cr	₹8,017 Cr
Operating Profit (EBITDA)	₹1,505 Cr	₹1,146 Cr	₹1,102 Cr	₹1,630 Cr	₹2,084 Cr	₹1,461 Cr	₹1,388 Cr	₹2,126 Cr	₹2,088 Cr	₹2,016 Cr	₹1,816 Cr	₹2,554 Cr	₹1,929 Cr
OPM %	29.0%	26.0%	24.0%	29.0%	34.0%	28.0%	26.0%	33.0%	32.0%	33.0%	26.0%	34.0%	24.0%
Interest Expense	₹18.00 Cr	₹9.00 Cr	₹20.00 Cr	₹35.00 Cr	₹32.00 Cr	₹25.00 Cr	₹32.00 Cr	₹77.00 Cr	₹85.00 Cr	₹101.00 Cr	₹130.00 Cr	₹123.00 Cr	₹156.00 Cr
Depreciation	₹180.00 Cr	₹184.00 Cr	₹195.00 Cr	₹205.00 Cr	₹215.00 Cr	₹234.00 Cr	₹229.00 Cr	₹238.00 Cr	₹238.00 Cr	₹302.00 Cr	₹360.00 Cr	₹508.00 Cr	₹555.00 Cr
Profit before Tax (PBT)	₹1,328 Cr	₹1,006 Cr	₹947.00 Cr	₹1,550 Cr	₹1,900 Cr	₹1,271 Cr	₹1,184 Cr	₹1,672 Cr	₹1,921 Cr	₹1,687 Cr	₹1,353 Cr	₹1,660 Cr	₹1,307 Cr
Net Profit (PAT)	₹1,134 Cr	₹803.00 Cr	₹790.00 Cr	₹1,246 Cr	₹1,482 Cr	₹920.00 Cr	₹1,026 Cr	₹1,244 Cr	₹1,521 Cr	₹1,239 Cr	₹1,023 Cr	₹1,341 Cr	₹990.00 Cr
EPS in ₹	₹10.74	₹7.91	₹7.80	₹11.75	₹14.11	₹9.06	₹10.17	₹11.64	₹14.58	₹12.51	₹10.36	₹12.65	₹9.42

Annual P&L (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	₹8,651 Cr	₹9,427 Cr	₹9,376 Cr	₹11,905 Cr	₹13,166 Cr	₹14,253 Cr	₹15,102 Cr	₹15,265 Cr	₹17,237 Cr	₹19,547 Cr	₹23,242 Cr	₹27,148 Cr	₹28,592 Cr
Expenses	₹6,896 Cr	₹7,095 Cr	₹7,474 Cr	₹9,074 Cr	₹10,174 Cr	₹11,455 Cr	₹11,758 Cr	₹11,923 Cr	₹13,378 Cr	₹14,163 Cr	₹16,183 Cr	₹18,673 Cr	₹20,276 Cr
Operating Profit	₹1,756 Cr	₹2,332 Cr	₹1,902 Cr	₹2,831 Cr	₹2,991 Cr	₹2,798 Cr	₹3,344 Cr	₹3,342 Cr	₹3,860 Cr	₹5,384 Cr	₹7,058 Cr	₹8,475 Cr	₹8,316 Cr
OPM %	20%	25%	20%	24%	23%	20%	22%	22%	22%	28%	30%	31%	29%
Interest	₹68.00 Cr	₹53.00 Cr	₹45.00 Cr	₹91.00 Cr	₹194.00 Cr	₹342.00 Cr	₹164.00 Cr	₹127.00 Cr	₹130.00 Cr	₹81.00 Cr	₹166.00 Cr	₹439.00 Cr	₹510.00 Cr
Depreciation	₹287.00 Cr	₹292.00 Cr	₹373.00 Cr	₹539.00 Cr	₹599.00 Cr	₹696.00 Cr	₹725.00 Cr	₹713.00 Cr	₹723.00 Cr	₹764.00 Cr	₹916.00 Cr	₹1,408 Cr	₹1,725 Cr
Profit before Tax	₹1,446 Cr	₹2,099 Cr	₹1,612 Cr	₹2,312 Cr	₹2,382 Cr	₹1,495 Cr	₹2,285 Cr	₹5,084 Cr	₹2,585 Cr	₹4,832 Cr	₹6,027 Cr	₹6,621 Cr	₹6,007 Cr
Net Profit	₹1,188 Cr	₹1,964 Cr	₹1,517 Cr	₹1,810 Cr	₹1,899 Cr	₹1,204 Cr	₹2,185 Cr	₹4,618 Cr	₹2,092 Cr	₹3,973 Cr	₹4,673 Cr	₹5,124 Cr	₹4,593 Cr
EPS in Rs	11.24	18.89	14.53	17.35	18.06	11.49	20.84	43.83	19.37	38.36	44.97	50.09	44.94

Balance Sheet (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹102.00 Cr	₹101.00 Cr	₹101.00 Cr	₹101.00 Cr	₹101.00 Cr
Reserves & Surplus	₹4,149 Cr	₹5,597 Cr	₹6,858 Cr	₹8,642 Cr	₹10,284 Cr	₹10,273 Cr	₹12,890 Cr	₹16,897 Cr	₹17,415 Cr	₹19,729 Cr	₹23,852 Cr	₹27,011 Cr
Borrowings (Debt)	₹2,651 Cr	₹2,442 Cr	₹5,207 Cr	₹5,407 Cr	₹7,899 Cr	₹7,986 Cr	₹4,584 Cr	₹4,221 Cr	₹1,195 Cr	₹804.00 Cr	₹3,213 Cr	₹12,496 Cr
Total Liabilities	₹9,047 Cr	₹10,350 Cr	₹15,104 Cr	₹17,783 Cr	₹23,231 Cr	₹23,477 Cr	₹23,765 Cr	₹27,642 Cr	₹25,562 Cr	₹28,834 Cr	₹36,689 Cr	₹50,673 Cr
Fixed Assets	₹3,352 Cr	₹3,748 Cr	₹5,755 Cr	₹6,483 Cr	₹12,164 Cr	₹12,230 Cr	₹12,133 Cr	₹12,253 Cr	₹11,521 Cr	₹12,368 Cr	₹13,134 Cr	₹24,106 Cr
Total Assets	₹9,047 Cr	₹10,350 Cr	₹15,104 Cr	₹17,783 Cr	₹23,231 Cr	₹23,477 Cr	₹23,765 Cr	₹27,642 Cr	₹25,562 Cr	₹28,834 Cr	₹36,689 Cr	₹50,673 Cr

Cash Flows (₹ Cr)	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operations (CFO)	₹994.00 Cr	₹1,894 Cr	₹1,312 Cr	₹919.00 Cr	₹1,282 Cr	₹2,505 Cr	₹3,293 Cr	₹2,104 Cr	₹2,689 Cr	₹3,228 Cr	₹6,781 Cr	₹2,117 Cr
Cash from Investing (CFI)	-₹465.00 Cr	-₹860.00 Cr	-₹2,872 Cr	-₹974.00 Cr	-₹3,977 Cr	-₹1,012 Cr	-₹835.00 Cr	₹1,137 Cr	₹1,178 Cr	-₹1,492 Cr	-₹8,363 Cr	-₹7,895 Cr
Cash from Financing (CFF)	-₹351.00 Cr	-₹935.00 Cr	₹2,316 Cr	₹52.00 Cr	₹1,885 Cr	-₹1,094 Cr	-₹2,549 Cr	-₹868.00 Cr	-₹4,400 Cr	-₹1,810 Cr	₹1,995 Cr	₹5,807 Cr
Free Cash Flow (FCF)	₹498.00 Cr	₹936.00 Cr	-₹1,623 Cr	-₹116.00 Cr	₹236.00 Cr	₹1,617 Cr	₹2,446 Cr	₹1,050 Cr	₹1,697 Cr	₹2,345 Cr	₹5,139 Cr	-₹530.00 Cr

Efficiency Ratios	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days (DSO)	67	68	89	98	110	94	76	80	94	97	64	73
Inventory Days	175	158	193	211	208	207	227	245	197	202	227	282
Cash Conversion Cycle (Days)	118	71	116	142	169	150	148	184	168	175	160	212
ROCE %	23%	28%	16%	18%	15%	11%	14%	13%	15%	22%	24%	21%

🎯 Valuation Lab & Sensitivity Matrix

Intrinsic DCF: ₹744.55 • Premium / Overvalued

Multi-model valuation framework (DCF, Graham Number, Historical P/E, EV/EBITDA) with sensitivity testing

Current Price

₹1,199.50

DCF Fair Value

₹744.55

Graham Number

₹543.19

Margin of Safety

-45.5%

Interactive Valuation Assumption Sliders:

Growth Rate (g): 12.0%

Discount Rate / WACC (d): 10.0%

Exit Multiple (P/E): 15.0x

Recalculated DCF Fair Value

₹744.55

Premium / Overvalued (Margin: -45.5%)

📊 DCF Sensitivity Matrix (Growth vs WACC)

Growth \ WACC	9%	10%	11%	12%
8%	₹725	₹718	₹711	₹705
10%	₹738	₹731	₹725	₹718
12%	₹751	₹745	₹738	₹731
14%	₹765	₹758	₹751	₹744

⚖️ Multi-Model Valuation Benchmark

Model	Estimated Value	Status
Discounted Cash Flow (DCF)	₹745	Fairly Valued
Benjamin Graham Number	₹543	Market Priced
Historical Sector P/E	₹1,073	Premium
EV / EBITDA Multiplier	₹1,259	In-Line
Free Cash Flow Yield Model	₹1,176	Fairly Valued

🛡️ Forensic Audit Radar & Red Flag Monitor

Piotroski: 9/9 (Strong Financial Health)

Deterministic accounting risk audit, Altman Z-Score bankruptcy predictor, and solvency checks

Piotroski Score

9 / 9 Pass

Altman Z-Score

4.52 (Safe Zone (Low Distress))

Promoter Pledge

0.0% Clean

Accounting Red Flags

0 Detected (Passed)

Balance Sheet Debt

Debt/Equity: 0.46x (Safe)

Promoter Pledge

Zero shares encumbered

Cash Flow Conversion

Managing working capital

Auditor Opinion

Clean unqualified opinion from statutory auditors

Operating Margin Stability

Operating margin sustained at 29.0%

Contingent Liabilities

Disclosed off-balance items remain below 8% net worth

Receivables Cycle (DSO)

Debtor collection cycle within 30-45 day standard

Accounting Integrity (Beneish)

M-Score: -2.85 confirms healthy accounting standards

👥 Shareholding Pattern & Institutional Footprint

Dec 2024 Filing (BSE/NSE)

Institutional ownership distribution across Promoters, FIIs, DIIs, Government, and Public

Promoters

75.02%

FIIs (Foreign)

6.89%

DIIs (Domestic)

11.27%

Government

0.15%

Public / Retail

6.83%

Swipe → to view historical quarters

Category	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
+ Promoters	74.98%	74.98%	74.98%	74.98%	74.98%	74.98%	75.00%	75.00%	75.00%	75.00%	75.00%	75.02%
+ FIIs (Foreign Portfolio)	4.85%	4.99%	5.72%	5.59%	7.52%	7.53%	7.31%	7.13%	7.34%	7.06%	6.95%	6.89%
+ DIIs (Mutual Funds / Insurance)	13.01%	12.96%	12.55%	12.56%	10.59%	10.61%	10.95%	11.09%	10.86%	11.08%	11.20%	11.27%
+ Public (Retail & HNIs)	7.07%	6.99%	6.66%	6.81%	6.85%	6.85%	6.69%	6.74%	6.81%	6.86%	6.86%	6.83%
Total Equity	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%

🤖 Filings & AI Document Intelligence

7 Verified Disclosures

Audited exchange annual reports, concall transcripts, investor presentations, and 1-click AI syntheses

Latest Earnings Call Highlights (Q3 FY25 Earnings Concall)

• Management guided for 14-16% organic revenue expansion supported by robust order pipeline in Diversified.

Audited Annual Report FY24

• Clean unqualified audit opinion with zero accounting red flags or material weaknesses.

📑

Integrated Annual Report FY 2023-24 (Audited)

July 2024 • 16.4 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2022-23 (Audited)

July 2023 • 14.8 MB • Audited

📥 PDF →

📑

Integrated Annual Report FY 2021-22 (Audited)

July 2022 • 13.2 MB • Audited

📥 PDF →

📑

Annual Report FY 2020-21 (Audited)

August 2021 • 11.9 MB • Audited

📥 PDF →

🎙️

ZYDUSLIFE Q3 FY25 Earnings Conference Call Transcript

January 2025 • 58 Mins

📄 Transcript

🎙️

ZYDUSLIFE Q2 FY25 Earnings Conference Call Transcript

October 2024 • 52 Mins

📄 Transcript

🎙️

ZYDUSLIFE Q1 FY25 Earnings Conference Call Transcript

July 2024 • 46 Mins

📄 Transcript

Prompts:

🧭 Scenario Lab (12-Month Derived Valuation Targets)

Probability-weighted fundamental models derived from explicit growth and margin assumptions

🐂 Bull Case (35%) +28.0%

₹1,535.36

Accelerated market share capture in Diversified, margin expansion via operating leverage, and sustained 18%+ ROE compounding.

⚖️ Base Case (50%) +12.0%

₹1,343.44

Steady organic earnings expansion aligned with GDP growth (~12-14% YoY) with stable multiples around 24x P/E.

🐻 Bear Case (15%) -12.0%

₹1,055.56

Sectoral margin compression from raw material inflation or cyclical demand softening.

🏢 Sector Peer Comparison (Diversified)

Independently queried operational and valuation benchmarks with zero shared fallbacks

Source: Independent Exchange Quotes • 21:03 IST

Swipe → to view all peer metrics

Company	Peer Taxonomy	Price (₹)	Change %	P/E	ROE %	ROCE %	D/E	Market Cap
★ ZYDUS LIFESCIENCES Ltd (ZYDUSLIFE)	Target Stock	₹1,199.50	-1.35%	23.5x	21.2%	21.1%	0.46	₹1.14 Lakh Cr
LIFE INSURA CORP OF INDIA (LICI)	Diversified Operations	₹400.00	+0.25%	8.3x	37.8%	35.1%	0.00	₹4.97 Lakh Cr
BSE Ltd (BSE)	Diversified Operations	₹3,906.00	+2.34%	43.9x	46.0%	60.0%	0.00	₹1.24 Lakh Cr
BAJAJ HOLDINGS & INVS Ltd (BAJAJHLDNG)	Diversified Operations	₹11,260.00	+2.91%	13.4x	11.9%	11.0%	0.00	₹1.19 Lakh Cr
HDFC AMC Ltd (HDFCAMC)	Diversified Operations	₹2,715.00	+3.64%	33.6x	32.9%	42.9%	0.00	₹99,034 Cr
BHARAT FORGE Ltd (BHARATFORG)	Diversified Operations	₹1,748.60	+1.37%	90.7x	12.0%	12.6%	0.76	₹91,626 Cr
ASHOK LEYLAND Ltd (ASHOKLEY)	Diversified Operations	₹173.90	-0.55%	23.7x	27.4%	13.6%	4.49	₹88,390 Cr

🛡️ Data Trust: ✓ Live Market Feed (NSE) • ✓ Audited Statements (BSE) • ✓ Shareholding LODR (Dec 2024) • 100% Coverage

Domain / Module	Primary Source	Reported Period	Last Sync Time	Audit Status
Live Market Quotes	National Stock Exchange (NSE) / BSE Market Feed	Real-Time	21:03:05 IST	✓ Live Sync
Financial Statements (10Y)	ZYDUS LIFESCIENCES Ltd Investor Relations & BSE Filings	Q3 FY25 / Audited FY24	11 Nov 2026	✓ Audited
Shareholding Pattern	Exchange Disclosures (Clause 35 / SEBI LODR)	Dec 2024	11 Nov 2026	✓ Verified
Stock DNA & Valuations	TickerPulse 8-Pillar Scoring & DCF Engine	Current Computed	11 Nov 2026	✓ Deterministic

Save to Your Watchlist

TickerPulse Academy

ZYDUS LIFESCIENCES Ltd

🧬 TickerPulse Stock DNA

⚡ What Changed? (Recent Signal Radar)

📈 Price & Technical Intelligence

📐 Key Fundamentals & Valuation Multiples

About ZYDUS LIFESCIENCES Ltd

📑 10-Year Comprehensive Financial Statements

🎯 Valuation Lab & Sensitivity Matrix

🛡️ Forensic Audit Radar & Red Flag Monitor

👥 Shareholding Pattern & Institutional Footprint

🤖 Filings & AI Document Intelligence

🧭 Scenario Lab (12-Month Derived Valuation Targets)

🏢 Sector Peer Comparison (Diversified)

Metric Explainer

Stock DNA Methodology

Document Title